Targeted Regulation of PI3K/Akt/mTOR/NF-κB Signaling by Indole Compounds and their Derivatives: Mechanistic Details and Biological Implications for Cancer Therapy

被引:226
作者
Ahmad, Aamir [1 ]
Biersack, Bernhard [3 ]
Li, Yiwei [1 ]
Kong, Dejuan [1 ]
Bao, Bin [1 ]
Schobert, Rainer [3 ]
Padhye, Subhash B. [4 ]
Sarkar, Fazlul H. [1 ,2 ]
机构
[1] Wayne State Univ, Karmanos Canc Inst, Dept Pathol, Sch Med, Detroit, MI 48201 USA
[2] Wayne State Univ, Karmanos Canc Inst, Dept Oncol, Sch Med, Detroit, MI 48201 USA
[3] Univ Bayreuth, Organ Chem Lab, D-95447 Bayreuth, Germany
[4] MCE Soc Abeda Inamdar Senior Coll Arts Sci & Comm, Dept Chem, ISTRA, Pune 411001, Maharashtra, India
关键词
Indole compounds; PI3K; cancer therapy; NF-kappa B; Glucosinolates; NF-KAPPA-B; EPITHELIAL-MESENCHYMAL TRANSITION; MAMMALIAN TARGET; INDOLE-3-CARBINOL-INDUCED APOPTOSIS; DIETARY INDOLE-3-CARBINOL; LUNG ADENOCARCINOMA; BRASSICA VEGETABLES; PANCREATIC-CANCER; MOLECULAR TARGETS; CERVICAL-CANCER;
D O I
10.2174/18715206113139990078
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
Indole compounds, found in cruciferous vegetables, are potent anti-cancer agents. Studies with indole-3-carbinol (I3C) and its dimeric product, 3,3'-diindolylmethane (DIM) suggest that these compounds have the ability to deregulate multiple cellular signaling pathways, including PI3K/Akt/mTOR signaling pathway. These natural compounds are also effective modulators of downstream transcription factor NF-kappa B signaling which might help explain their ability to inhibit invasion and angiogenesis, and the reversal of epithelial-to-mesenchymal transition (EMT) phenotype and drug resistance. Signaling through PI3K/Akt/mTOR and NF-kappa B pathway is increasingly being realized to play important role in EMT through the regulation of novel miRNAs which further validates the importance of this signaling network and its regulations by indole compounds. Here we will review the available literature on the modulation of PI3K/Akt/mTOR/NF-kappa B signaling by both parental I3C and DIM, as well as their analogs/derivatives, in an attempt to catalog their anticancer activity.
引用
收藏
页码:1002 / 1013
页数:12
相关论文
共 124 条
[1]
Acharya Asha, 2010, Recent Pat Food Nutr Agric, V2, P166, DOI 10.2174/1876142911002020166
[2]
Molecular targets and anticancer potential of indole-3-carbinol and its derivatives [J].
Aggarwal, BB ;
Ichikawa, H .
CELL CYCLE, 2005, 4 (09) :1201-1215
[3]
Ahmad A., 2012, MOL CANC THER
[4]
Phosphoglucose Isomerase/Autocrine Motility Factor Mediates Epithelial-Mesenchymal Transition Regulated by miR-200 in Breast Cancer Cells [J].
Ahmad, Aamir ;
Aboukameel, Amro ;
Kong, Dejuan ;
Wang, Zhiwei ;
Sethi, Seema ;
Chen, Wei ;
Sarkar, Fazlul H. ;
Raz, Avraham .
CANCER RESEARCH, 2011, 71 (09) :3400-3409
[5]
Ahmad Aamir, 2009, Curr Aging Sci, V2, P174
[6]
Anticancer Properties of Indole Compounds: Mechanism of Apoptosis Induction and Role in Chemotherapy [J].
Ahmad, Aamir ;
Sakr, Wael A. ;
Rahman, K. M. Wahidur .
CURRENT DRUG TARGETS, 2010, 11 (06) :652-666
[7]
Ahmadi Alireza, 2011, J Inj Violence Res, V3, P55, DOI [10.1016/j.jecm.2011.01.001, 10.5249/jivr.v3i1.28]
[8]
Attenuation of multi-targeted proliferation-linked signaling by 3,3′-diindolylmethane (DIM): From bench to clinic [J].
Banerjee, Sanjeev ;
Kong, Dejuan ;
Wang, Zhiwei ;
Bao, Bin ;
Hillman, Gilda G. ;
Sarkar, Fazlul H. .
MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH, 2011, 728 (1-2) :47-66
[9]
Phase III randomized trial of sunitinib versus capecitabine in patients with previously treated HER2-negative advanced breast cancer [J].
Barrios, Carlos H. ;
Liu, Mei-Ching ;
Lee, Soo Chin ;
Vanlemmens, Laurence ;
Ferrero, Jean-Marc ;
Tabei, Toshio ;
Pivot, Xavier ;
Iwata, Hiroji ;
Aogi, Kenjiro ;
Lugo-Quintana, Roberto ;
Harbeck, Nadia ;
Brickman, Marla J. ;
Zhang, Ke ;
Kern, Kenneth A. ;
Martin, Miguel .
BREAST CANCER RESEARCH AND TREATMENT, 2010, 121 (01) :121-131
[10]
RETRACTED: Down-regulation of androgen receptor by 3,3'-diindolylmethane contributes to inhibition of cell proliferation and induction of apoptosis in both hormone-sensitive LNCaP and insensitive C4-2B prostate cancer cells (Retracted article. See vol. 78, pg. 5473, 2018) [J].
Bhuiyan, Mohammad M. R. ;
Li, Yiwei ;
Banerjee, Sanjeev ;
Ahmed, Fakhara ;
Wang, Zhiwei ;
Ali, Shadan ;
Sarkar, Fazlul H. .
CANCER RESEARCH, 2006, 66 (20) :10064-10072